Srilata Gundala, M.D.
Hematology & Oncology Physician · Hinsdale, IL
Srilata Gundala, M.D. is a hematology & oncology physician with a practice address in Hinsdale, Illinois, and NPI 1467646141, issued on Sep 5, 2007. Check the license (Illinois 036.124518, as entered in NPPES) on the Illinois Department of Financial and Professional Regulation; the Medicare figures below come from public CMS files.
- Name
- Srilata Gundala
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 036.124518 IL
Self-reported in NPPES; status is on the state search - Practice location
- 950 N York RD Ste 201A, Hinsdale, IL 60521
- Phone
- (630) 560-0121
- Enumerated
- Sep 5, 2007
- Record last updated
- Apr 15, 2022
- Fax
- (630) 214-0110
- Medicare enrollment
- Enrolled (PECOS I20100312000941); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 666 in Illinois → Look up another NPI →
Verify Srilata Gundala in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersIllinois Department of Financial and Professional Regulation
Search for license 036.124518Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
49% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
446 Medicare Part D claims for 75 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 35% of claims. 13 claims were for opioids.
Most prescribed
- Anastrozole75 claims
- Lenalidomide24 claims
- Ondansetron Odt22 claims
- Valacyclovir19 claims
- Prochlorperazine Maleate18 claims
- Darzalex15 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $2,798.92
104 payments; by number, the most common kind was food and beverage; the largest payer was Novartis Pharmaceuticals Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Hope And Healing Cancer Services LLCHinsdale, IL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Srilata Gundala among 666 hematology & oncology physician records in Illinois
Srilata Gundala, M.D. is one of 666 hematology & oncology physician records with a practice address in Illinois. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 43% of them.
- NPI issued2007 · 43% of these records are older, 48% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 69% of these records are
- Graduated1997 · median 2003 among the 461 with a school on file
- Record last updated2022 · 49% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Illinois practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Illinois
There are 666 hematology & oncology physician records in Illinois.
All 666 in Illinois → Every provider in Hinsdale → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Daniel Chakos, M.D.Hinsdale, IL 605211487034674
- Jay Dalal, MDHinsdale, IL 605211770627184
- Rekha Harting, M.D.Hinsdale, IL 605211467659318
- Renee Jacobs, MDHinsdale, IL 605211790846525
- Arti Lakhani, M.D.Hinsdale, IL 605211831345818
- Patricia Madej, MDHinsdale, IL 605211124009642
- Megan Moroney, APRNHinsdale, IL 605211356153944
- Kristin Richardson, M.D.Hinsdale, IL 605211104266980
Common questions
What is Srilata Gundala, M.D.'s NPI number?
Srilata Gundala, M.D.'s National Provider Identifier (NPI) is 1467646141, issued on Sep 5, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Srilata Gundala, M.D. located?
The NPPES record lists a practice address at 950 N York RD Ste 201A, Hinsdale, IL, 60521. Phone: (630) 560-0121. Providers update this record themselves, so call before visiting.
How can I verify Srilata Gundala, M.D.'s license?
NPPES lists Illinois license number 036.124518, as entered by the provider. Search the Illinois Department of Financial and Professional Regulation at https://idfpr.illinois.gov/checklicense.html. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Srilata Gundala, M.D. prescribe under Medicare Part D?
In 2024, Srilata Gundala, M.D. had 446 Medicare Part D claims for 75 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.